
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PLRZ market cap is 1.41M. The company's latest EPS is USD -0.3683 and P/E is -0.92.
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -72k | -703k | -895k | -635k | -1.3M |
Net Income | -73k | -711k | -779k | -600k | -1.55M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 24k | 687k | 546k | 559k | 5.55M |
Total Liabilities | 8k | 690k | 1.2M | 502k | 261k |
Total Equity | -232k | -251k | -900k | -191k | 5.29M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | |||||
Investing | |||||
Financing |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -73k | -492k | -1.13M | -537k | -1.15M |
Investing | -6k | -19k | -3k | N/A | 29k |
Financing | 89k | 1.02M | 648k | 505k | 3.67M |
Market Cap | 1.41M |
Price to Earnings Ratio | -0.92 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.56 |
Price to Book Ratio | 0.27 |
Dividend Yield | - |
Shares Outstanding | 4.19M |
Average Volume (1 week) | 57.72k |
Average Volume (1 Month) | 225.21k |
52 Week Change | -79.57% |
52 Week High | 4.80 |
52 Week Low | 0.2806 |
Spread (Intraday) | 2.12 (86.88%) |
Company Name | Polyrizon Ltd |
Address |
5 ha-tidhar street ra'anana, center 4366507 |
Website | https://www.polyrizon-biotech.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions